Apimeds Pharmaceuticals US (APUS) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Jaguar Health is the larger company by market cap ($8.6 million vs $8.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | APUS | JAGX |
|---|---|---|
| Share price | $5.69 | $4.43 |
| Market cap | $8.59M | $8.63M |
| 1-day change | -19.32% | -11.33% |
| YTD return | -57.01% | — |
| 1-year return | -58.77% | — |
| EPS (TTM) | $-36.03 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $1,267.88 |
| 52-week low | $1.51 | $2.35 |
| Distance from 52-week high | -90.47% | -99.65% |
| Average volume | 3.65M | 2.00M |
| Shares outstanding | 1.51M | 1.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
APUS vs JAGX FAQ
Which is bigger, Apimeds Pharmaceuticals US or Jaguar Health?
Jaguar Health (JAGX) is larger, with a market capitalization of $8.63M compared with $8.59M for Apimeds Pharmaceuticals US (APUS).
Are Apimeds Pharmaceuticals US and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.